Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd is set to showcase its innovative medical devices at the Coffee Microcaps Morning Meeting with CEO Jeremy Steele leading the ...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com made losses for many years after listing, if you had bought and held the shares ...

Control Bionics Ltd. (AU:CBL) has released an update. Control Bionics Ltd. has presented its next-generation assistive technology and data measurement solutions, aiming to enhance user experience and ...

Control Bionics progresses, expanding its market reach and product use NeuroNode Only sales model launched in US following Medicare reimbursement code NeuroStrip gaining traction in sports science, ...

Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence. Subscribe to TipRanks' Smart Investor Picks and see our data in action through our ...

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

PERTH, Australia – Med-tech company Control Bionics began trading on the Australian Securities Exchange (ASX:CBL) Dec. 7 in an IPO that saw the company raise AU$15 million (US$11.25 million).

Control Bionics Ltd (ASX:CBL)'s newly announced US joint venture with NextLevel Assistive Technology will enable it to scale into the largest segment of the American augmentative and alternative ...